Article Details

Insider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells 50000 Shares of Stock

Retrieved on: 2021-06-08 00:33:45

Tags for this article:

Click the tags to see associated articles and topics

Insider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells 50000 Shares of Stock. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 18,481,307 shares of the biopharmaceutical company's stock valued at $789,337,000 after acquiring an additional 5,272,072 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up